Enrolling Studies
- A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
- A Study of Remternetug (LY3372993) in Early Alzheimer’s Disease (TRAILRUNNER-ALZ 3)
- Long-Term Real-World Comparative Effectiveness of Donanemab Plus Usual Care Versus Usual Care Alone in US Patients With Early Symptomatic Alzheimer’s Disease (TRAILBLAZER-REAL US)
- A Randomized, Double-Blinded Study to Evaluate the Efficacy and Safety of Mevidalen in Patients With Alzheimer’s Disease
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab (FILIOS)
- Study to Evaluate the Maintenance of Efficacy When Transitioning From Anti-CD20 Therapy to Ublituximab (ENHANCE)
- MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® (MS-DETECT)